When you should NOT pursue Mounjaro (the steelman argument) The strongest argument against pursuing Mounjaro, even if you qualify, centers on three scenarios: Scenario 1: You have untreated binge eating disorder Tirzepatide suppresses appetite through delayed gastric emptying and central nervous system effects
These trials were randomized, double-blind, and placebo-controlled
Serious medical concerns Some of the serious concerns with increasing access include: Pancreatitis, Thyroid-related risks, Severe gastric slowing, gall bladder issues, misuse for cosmetic weight loss, self-medication without supervision, muscle loss if not combined with proper nutrition, and weight regain after stopping
Read below if youre considering this supplement
GLP-Squared Injection: When One Peptide Isn't Enough GLP-Squared injection combines compounded semaglutide and tirzepatide in a single formulation, offering synergistic metabolic benefits when single-agent therapy plateaus